Sildenafil Citrate Tablet
Product Images NDC 82804-251

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 82804-251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-251-11 (Sildenafil Citrate 25 mg 30s)

82804-251-11 (Sildenafil Citrate 25 mg 30s)
The text provides details about sildenafil tablets, each containing 25mg of Sildenafil citrate USP. The tablets are round, pale blue to blue in color, film-coated, and imprinted with "25" on one side and "SL" on the other. The medication is packaged by Proficient Rx LP in Thousand Oaks, CA, and manufactured by Umedica Laboratories Pvt. Ltd. in India. It is advised to store the tablets at 25°C (77°F) and keep them out of the reach of children.*
FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)
This text contains data related to blood pressure change. It shows the mean standing systolic blood pressure change from baseline. The figures listed suggest measurements and calculations related to blood pressure.*
FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)
This text contains information related to a study comparing the effects of Doxazosin and Sildenafil on systolic blood pressure change from the baseline. The chart depicts the mean standing systolic blood pressure change over different time points. The data points are classified for Doxazosin, Placebo, and Sildenafil.*
FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)
This text shows a chart displaying the change in mean standing systolic blood pressure from baseline following the administration of 100 ng of Doxazosin.*
FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)
This text appears to be a summary of an assessment related to purchasing and importing sildenafil citrate. It includes percentages, measurements (35 mg, 100 mg), and potentially data on prices (e.g., the equalities "=$214 vy =380"). The text mentions a "Prrcasinge pitisaismporing Inpessment" and the effectiveness of the treatment provided.*
FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.